Dalbavancin
- $33 - $3728.1
- Product name: Dalbavancin
- CAS: 171500-79-1
- MF: C88H100Cl2N10O28
- MW: 1816.71
- EINECS:206-141-6
- MDL Number:MFCD09837770
- Synonyms:Dalbavancin;MDL 63397;A-A-1, Dalbavancin Ao, BI 397, MDL 63397;Dalbavancin(BI 397, MDL 63397);CS-2250;Dalbavancin Ao;Dalbavancin(BI 397;DALBAVANCIN;MDL 63397;A-A-1; DALBAVANCIN AO; BI 397; MDL 63397;DALBAVANCIN(BI 397; MDL 63397)
18 prices
Selected condition:
Brand
- American Custom Chemicals Corporation
- Biorbyt Ltd
- Cayman Chemical
- Crysdot
- DC Chemicals
- Medical Isotopes, Inc.
- Sigma-Aldrich
- TRC
- Usbiological
Package
- 1MG
- 5MG
- 10mg
- 25mg
- 50mg
- 100mg
- 250mg
- 1g
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberAPI0006010
- Product descriptionDALBAVANCIN 95.00%
- Packaging1MG
- Price$262.5
- Updated2021-12-16
- Buy
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberAPI0006010
- Product descriptionDALBAVANCIN 95.00%
- Packaging5MG
- Price$503.29
- Updated2021-12-16
- Buy
- ManufacturerBiorbyt Ltd
- Product numberorb134798
- Product descriptionDalbavancin >99%
- Packaging100mg
- Price$1030.2
- Updated2021-12-16
- Buy
- ManufacturerBiorbyt Ltd
- Product numberorb134798
- Product descriptionDalbavancin >99%
- Packaging250mg
- Price$1949.9
- Updated2021-12-16
- Buy
- ManufacturerBiorbyt Ltd
- Product numberorb134798
- Product descriptionDalbavancin >99%
- Packaging1g
- Price$3728.1
- Updated2021-12-16
- Buy
- ManufacturerCayman Chemical
- Product number21161
- Product descriptionDalbavancin ≥98%
- Packaging1mg
- Price$33
- Updated2024-03-01
- Buy
- ManufacturerCayman Chemical
- Product number21161
- Product descriptionDalbavancin ≥98%
- Packaging5mg
- Price$83
- Updated2024-03-01
- Buy
- ManufacturerCayman Chemical
- Product number21161
- Product descriptionDalbavancin ≥98%
- Packaging10mg
- Price$131
- Updated2024-03-01
- Buy
- ManufacturerCayman Chemical
- Product number21161
- Product descriptionDalbavancin ≥98%
- Packaging25mg
- Price$286
- Updated2024-03-01
- Buy
- ManufacturerCrysdot
- Product numberCD31003009
- Product descriptionDalbavancin 98+%
- Packaging5mg
- Price$158
- Updated2021-12-16
- Buy
- ManufacturerDC Chemicals
- Product numberDCAPI1493
- Product descriptionDalbavancin >99%
- Packaging100mg
- Price$680
- Updated2021-12-16
- Buy
- ManufacturerDC Chemicals
- Product numberDCAPI1493
- Product descriptionDalbavancin >99%
- Packaging250mg
- Price$1300
- Updated2021-12-16
- Buy
- ManufacturerDC Chemicals
- Product numberDCAPI1493
- Product descriptionDalbavancin >99%
- Packaging1g
- Price$2500
- Updated2021-12-16
- Buy
- ManufacturerMedical Isotopes, Inc.
- Product number39584
- Product descriptionDalbavancin
- Packaging10mg
- Price$590
- Updated2021-12-16
- Buy
- ManufacturerSigma-Aldrich
- Product numberSML2378
- Product descriptionDalbavancin ≥90% (HPLC)
- Packaging5mg
- Price$88.8
- Updated2024-03-01
- Buy
- ManufacturerSigma-Aldrich
- Product numberSML2378
- Product descriptionDalbavancin ≥90% (HPLC)
- Packaging25mg
- Price$359
- Updated2024-03-01
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
American Custom Chemicals Corporation | API0006010 | DALBAVANCIN 95.00% | 1MG | $262.5 | 2021-12-16 | Buy |
American Custom Chemicals Corporation | API0006010 | DALBAVANCIN 95.00% | 5MG | $503.29 | 2021-12-16 | Buy |
Biorbyt Ltd | orb134798 | Dalbavancin >99% | 100mg | $1030.2 | 2021-12-16 | Buy |
Biorbyt Ltd | orb134798 | Dalbavancin >99% | 250mg | $1949.9 | 2021-12-16 | Buy |
Biorbyt Ltd | orb134798 | Dalbavancin >99% | 1g | $3728.1 | 2021-12-16 | Buy |
Cayman Chemical | 21161 | Dalbavancin ≥98% | 1mg | $33 | 2024-03-01 | Buy |
Cayman Chemical | 21161 | Dalbavancin ≥98% | 5mg | $83 | 2024-03-01 | Buy |
Cayman Chemical | 21161 | Dalbavancin ≥98% | 10mg | $131 | 2024-03-01 | Buy |
Cayman Chemical | 21161 | Dalbavancin ≥98% | 25mg | $286 | 2024-03-01 | Buy |
Crysdot | CD31003009 | Dalbavancin 98+% | 5mg | $158 | 2021-12-16 | Buy |
DC Chemicals | DCAPI1493 | Dalbavancin >99% | 100mg | $680 | 2021-12-16 | Buy |
DC Chemicals | DCAPI1493 | Dalbavancin >99% | 250mg | $1300 | 2021-12-16 | Buy |
DC Chemicals | DCAPI1493 | Dalbavancin >99% | 1g | $2500 | 2021-12-16 | Buy |
Medical Isotopes, Inc. | 39584 | Dalbavancin | 10mg | $590 | 2021-12-16 | Buy |
Sigma-Aldrich | SML2378 | Dalbavancin ≥90% (HPLC) | 5mg | $88.8 | 2024-03-01 | Buy |
Sigma-Aldrich | SML2378 | Dalbavancin ≥90% (HPLC) | 25mg | $359 | 2024-03-01 | Buy |
Properties
Melting point :>160°C (dec.)
Density :1.59
storage temp. :-20°C
solubility :Aqueous Base (Slightly), DMSO (Slightly, Heated), Water (Slightly)
pka :2.73±0.70(Predicted)
form :powder
color :white to beige
Density :1.59
storage temp. :-20°C
solubility :Aqueous Base (Slightly), DMSO (Slightly, Heated), Water (Slightly)
pka :2.73±0.70(Predicted)
form :powder
color :white to beige
Safety Information
Symbol(GHS): | |||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Signal word: | Warning | ||||||||||||||||||||||||||||
Hazard statements: |
|
||||||||||||||||||||||||||||
Precautionary statements: |
|
Description
Dalbavancin is a second generation, semi-synthetic lipoglycopeptide antibiotic that is active against gram-positive pathogens with a MIC90for Staphylococcus aureus of 0.06 μg/mL. Dalbavancin possesses more potent in vitro bactericidal activity than vancomycin or teicoplanin against many resistant Gram-positive organisms such as MRSA. Dalbavanacin displays prolonged terminal half-life in adults.Compared to existing glycopeptides anti-MRSA(Methicillin-Resistant Staphylococcus Aureus) antibiotics, it has better antibiotic strength and, because it only needs to be taken once a week, it will be easier for both patients and medical care providers. It also offers stable absorption and metabolism for patients with light to moderate kidney and liver dysfunction. We know that its interactions with other medications are extremely small, and it is proving to be very safe in clinical trials.Dalbavancin is specifically indicated for the treatment of adult patients with acute bacterial skin and skin structure infections (ABSSSI) caused by susceptible isolates of the following Gram-positive microorganisms: Staphylococcus aureus (including methicillinsusceptible and methicillin-resistant strains), Streptococcus pyogenes, Streptococcus agalactiae and Streptococcus anginosus group (including S. anginosus, S. intermedius, S. constellatus).
Class Glycopeptide anti-MRSA antibiotic
Mechanism of Action Cell Wall Peptidoglycan Synthesis Inhibitor
Target Indication MRSA Infections
Related product price
- Sitafloxacin
$88-11880 - Cilastatin
$39-2450 - Betamethasone
$39-1504.5